CSB 2.012 HistoryHistory: Cr. Register, October, 1973, No. 214, eff. 11-1-73. CSB 2.012 NoteCSB 2.04 Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III. (1) Subsection (7) of s. 161.16, Stats., schedule II is hereby created to read as follows: CSB 2.012 Note(7) Unless excepted under federal regulations or listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
CSB 2.012 Note(a) Amobarbital
CSB 2.012 Note(b) Pentobarbital
CSB 2.012 Note(c) Secobarbital
CSB 2.012 Note(2) Paragraphs (m) and (n) of sub. (3), s. 161.18, Stats., schedule III, are hereby created to read as follows: CSB 2.012 Note(m) Unless excepted under federal regulations, any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
CSB 2.012 Note(n) Unless excepted under federal regulations, any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the federal food and drug administration for marketing only as a suppository.
CSB 2.012 HistoryHistory: Cr. Register, July, 1974, No. 223, eff. 8-1-74. CSB 2.012 NoteCSB 2.05 Addition of drotebanol to schedule I. The substance known as drotebanol is hereby added to s. 161.14, Stats., schedule I in sub. (3), par. (hm), which paragraph is created to read: CSB 2.012 Note(hm) Drotebanol;
CSB 2.012 HistoryHistory: Cr. Register, July, 1974, No. 223, eff. 8-1-74. CSB 2.012 NoteCSB 2.06 Addition of pentazocine to schedule III. Subsection (4m) of s. 161.18, Stats., schedule III is hereby created to read as follows: CSB 2.012 Note(4m) Pentazocine.
CSB 2.012 HistoryHistory: Cr. Register, August, 1974, No. 224, eff. 9-1-74. CSB 2.012 NoteCSB 2.07 Transfer of hydrochloride form of etorphine from schedule I to schedule II. (1) Subsection (3) (intro.) of s. 161.14, Stats., schedule I is amended to read: CSB 2.012 Note(3) Unless specifically excepted or listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
CSB 2.012 Note(2) Paragraph (em) of sub. (3), s. 161.16, Stats., schedule II, is hereby created to read: CSB 2.012 Note(em) Etorphine hydrochloride;
CSB 2.012 HistoryHistory: Cr. Register, August, 1974, No. 224, eff. 9-1-74. CSB 2.012 NoteCSB 2.08 Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV. (1) Paragraph (d) of sub. (2), s. 161.16, Stats., schedule II is hereby created to read: CSB 2.012 Note(d) Concentrate of poppy straw (the crude extract of Poppy Straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).
CSB 2.012 Note(2) Paragraph (n) of sub. (2) of s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(n) Mebutamate
CSB 2.012 Note(3) Paragraph (b) of sub. (2m) of s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(b) Pemoline:
CSB 2.012 HistoryHistory: Cr. Register, February, 1976, No. 242, eff. 3-1-76. CSB 2.012 NoteCSB 2.09 Additions to schedules IV and I. (1) Addition of benzodiazepine substances to schedule IV. Paragraphs (cm), (cn), (cp), (cr), (em) and (hm) of sub. (2), s. 161.20, Stats., schedule IV are hereby created to read: CSB 2.012 Note(cm) Chlordiazepoxide
CSB 2.012 Note(cn) Clonazepam
CSB 2.012 Note(cp) Chlorazepate
CSB 2.012 Note(cr) Diazepam
CSB 2.012 Note(em) Flurazepam
CSB 2.012 Note(hm) Oxazepam
CSB 2.012 Note(2) Addition of the thiophene analog of phencyclidine to schedule I. Paragraph (u) of sub. (4), s. 161.14, Stats., schedule I is hereby created to read: CSB 2.012 Note(u) Thiophene analog of phencyclidine
CSB 2.012 Note(3) Addition of mecloqualone to schedule I. Subsection (5) and par. (a) of s. 161.14, Stats., schedule I are hereby created to read: CSB 2.012 Note(5) Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
CSB 2.012 Note(a) Mecloqualone
CSB 2.012 Note(4) Addition of difenoxin to schedule I. Paragraph (hg) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read: CSB 2.012 Note(hg) Difenoxin
CSB 2.012 Note(5) Addition of 2,5 dimethoxyamphetamine, 4-romo-2,5 dimethoxyamphetamine and 4-methoxyamphetamine to schedule I. Paragraphs (v), (w) and (x) of sub. (4), s. 161.14, Stats., schedule I are hereby created to read: CSB 2.012 Note(v) 2,5-dimethoxyamphetamine
CSB 2.012 Note(w) 4-bromo-2,5-dimethoxyamphetamine
CSB 2.012 Note(x) 4-methoxyamphetamine
CSB 2.012 HistoryHistory: Cr. Register, April, 1976, No. 244, eff. 5-1-76. CSB 2.012 NoteCSB 2.10 Addition of propiram to schedule I. Paragraph (wn) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read: CSB 2.012 Note(wn) Propiram
CSB 2.012 HistoryHistory: Cr. Register, August, 1976, No. 248, eff. 9-1-76. CSB 2.012 NoteCSB 2.11 Renumbering and addition to schedule IV of diethylpropion and phentermine. Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
CSB 2.012 Note(b) Fenfluramine
CSB 2.012 NoteParagraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(a) Diethylpropion
CSB 2.012 NoteParagraph (b) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:
CSB 2.012 Note(c) Pemoline
CSB 2.012 NoteParagraph (d) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(d) Phentermine
CSB 2.012 HistoryHistory: Cr. Register, August, 1976, No. 248, eff. 9-1-76. CSB 2.012 NoteCSB 2.13 Addition of dextropropoxyphene to schedule IV. Subsection (4), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(4) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:
CSB 2.012 Note(a) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane)
CSB 2.012 HistoryHistory: Cr. Register, November, 1977, No. 263, eff. 12-1-77. CSB 2.012 NoteCSB 2.14 Addition of prazepam to schedule IV. Paragraph (km), sub. (2), s. 161.20, Stats., schedule IV is hereby created to read: CSB 2.012 Note(km) Prazepam
CSB 2.012 HistoryHistory: Cr. Register, November, 1977, No. 263, eff. 12-1-77. CSB 2.012 NoteCSB 2.15 Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV. (1) Paragraph (mn) of sub. (4), s. 161.14, Stats., is created to read: CSB 2.012 Note(mn) Parahexyl
CSB 2.012 Note(2) Paragraph (a) of sub. (3), s. 161.22, Stats., is repealed.
CSB 2.012 Note(3) Paragraph (nm) of sub. (2), s. 161.20, Stats., is created to read: CSB 2.012 Note(nm) Triazolam
CSB 2.012 HistoryHistory: Cr. Register, October, 1984, No. 346, eff. 11-1-84. CSB 2.012 NoteCSB 2.16 Transfer of sufentanil from schedule I to schedule II. (1) Section 161.14 (2) (xg), Stats., is repealed.
CSB 2.012 Note(y) Sufentanil
CSB 2.012 HistoryHistory: Cr. Register, October, 1984, No. 346, eff. 11-1-84. CSB 2.012 NoteCSB 2.17 Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II. (2) Paragraph (b) of s. 161.14 (5), Stats., is adopted to read: CSB 2.012 Note(b) Methaqualone
CSB 2.012 Note(3) Subsection (7) (am) of s. 161.16, Stats., is repealed.
CSB 2.012 Note(4) Subsection (10) (a) of s. 161.16, Stats., is created to read: CSB 2.012 Note(10) Hallucinogenic substances. (a) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6a R - trans) - 6a, 7, 8, 10a - tetrahydro - 6, 6, 9 - trimethyl - 3 -pentyl-6H-dibenzo (b, d) pyran - 1 - ol, or (-) - delta - 9 - (trans) - tetrahydrocannabinol.)
CSB 2.012 NoteCSB 2.18 Addition of 3,4-methylenedioxymethamphetamine to schedule I. Paragraph (am) of s. 161.14 (4), Stats., is created to read:
